Valeant and Allergan

Allergan: The Irvine, California, company also said Monday it plans to eliminate about 250 vacant positions in a restructuring that will streamline its business and allow the drugmaker to focus on its "highest value opportunities." , according to Canadian Broadcasting Corporation, CBC. CEO David Pyott is attempting to prove there is no need for the Valeant merger as Allergan can boost its earnings, cut spending and create better shareholder value on its own. Botox maker Allergan will cut about 13 per cent of its workforce, or roughly 1,500 employees, as part of a push to become more efficient and productive. Allergan is fighting a hostile takeover bid from Valeant Pharmaceuticals of Laval, Que. Valeant goes directly to shareholders on Allergan dea l Quebec Valeant boosts offer for Botox maker Allergan (news.financializer.com). As reported in the news.